European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
- PMID: 26160136
- DOI: 10.1530/EJE-15-0628
European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
Abstract
Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vitamin D analogues and calcium supplementation and not replacement of the lacking hormone, as in other hormonal deficiency states. The purpose of this guideline is to provide clinicians with guidance on the treatment and monitoring of chronic HypoPT in adults who do not have end-stage renal disease. We intend to draft a practical guideline, focusing on operationalized recommendations deemed to be useful in the daily management of patients. This guideline was developed and solely sponsored by The European Society of Endocrinology, supported by CBO (Dutch Institute for Health Care Improvement) and based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) principles as a methodological base. The clinical question on which the systematic literature search was based and for which available evidence was synthesized was: what is the best treatment for adult patients with chronic HypoPT? This systematic search found 1100 articles, which was reduced to 312 based on title and abstract. The working group assessed these for eligibility in more detail, and 32 full-text articles were assessed. For the final recommendations, other literature was also taken into account. Little evidence is available on how best to treat HypoPT. Data on quality of life and the risk of complications have just started to emerge, and clinical trials on how to optimize therapy are essentially non-existent. Most studies are of limited sample size, hampering firm conclusions. No studies are available relating target calcium levels with clinically relevant endpoints. Hence it is not possible to formulate recommendations based on strict evidence. This guideline is therefore mainly based on how patients are managed in clinical practice, as reported in small case series and based on the experiences of the authors.
© 2015 European Society of Endocrinology.
Similar articles
-
Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society.Hormones (Athens). 2020 Dec;19(4):581-591. doi: 10.1007/s42000-020-00195-w. Epub 2020 Apr 15. Hormones (Athens). 2020. PMID: 32297171 Review.
-
Management of hypoparathyroidism: a Position Statement of the Expert Group of the Polish Society of Endocrinology.Endokrynol Pol. 2023;74(5):447-467. doi: 10.5603/ep.96950. Endokrynol Pol. 2023. PMID: 37902011
-
A comparative quality assessment of evidence-based clinical guidelines in endocrinology.Clin Endocrinol (Oxf). 2013 Feb;78(2):183-90. doi: 10.1111/j.1365-2265.2012.04441.x. Clin Endocrinol (Oxf). 2013. PMID: 22624723
-
Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.J Bone Miner Res. 2022 Dec;37(12):2568-2585. doi: 10.1002/jbmr.4691. Epub 2022 Nov 14. J Bone Miner Res. 2022. PMID: 36054621
-
Hypoparathyroidism: Similarities and differences between Western and Eastern countries.Osteoporos Int. 2025 Mar;36(3):391-402. doi: 10.1007/s00198-024-07352-6. Epub 2025 Jan 8. Osteoporos Int. 2025. PMID: 39777494 Review.
Cited by
-
Prevalence of chronic postsurgical hypoparathyroidism not adequately controlled: an analysis of a nationwide cohort of 337 patients.Front Endocrinol (Lausanne). 2024 Sep 25;15:1464515. doi: 10.3389/fendo.2024.1464515. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39387052 Free PMC article.
-
Hypocalcemic cardiomyopathy: A case report.Front Cardiovasc Med. 2022 Sep 13;9:999550. doi: 10.3389/fcvm.2022.999550. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36176987 Free PMC article.
-
Outcome of parathyroid function after total thyroidectomy when calcium supplementation is administered routinely versus exclusively to symptomatic patients: A prospective randomized clinical trial.Endocrine. 2022 Feb;75(2):583-592. doi: 10.1007/s12020-021-02921-9. Epub 2021 Nov 8. Endocrine. 2022. PMID: 34748169 Clinical Trial.
-
Nephrocalcinosis in a 3-year-old child with hypocalcemia: Answers.Pediatr Nephrol. 2023 Aug;38(8):2565-2569. doi: 10.1007/s00467-022-05695-y. Epub 2022 Aug 4. Pediatr Nephrol. 2023. PMID: 35925425 No abstract available.
-
Effect of intraoperative active exploration of parathyroid glands to reduce the incidence of postoperative hypoparathyroidism, and risk factors of hypoparathyroidism after total thyroidectomy: a single-center study.Front Surg. 2023 Jul 21;10:1203595. doi: 10.3389/fsurg.2023.1203595. eCollection 2023. Front Surg. 2023. PMID: 37545843 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical